INTRODUCTION: Previously we reported that paracrine actions likely mediated the therapeutic effects of adipose tissue-derived stem cells (ADSCs) on a rat model of cavernous nerve (CN) injury. AIM: To identify potential neurotrophic factors in ADSC's secretion, test the most promising one, and identify the molecular mechanism of its neurotrophic action. METHODS: Rat major pelvic ganglia (MPG) were cultured in conditioned media of ADSC and penile smooth muscle cells (PSMCs). Cytokine expression in these two media was probed with a cytokine antibody array. CXCL5 cytokine was quantified in these two media by enzyme-linked immunosorbent assay (ELISA). Activation of Janus Kinase/Signal Transducer and Activator of Transcription (JAK/STAT) by CXCL5 was tested in neuroblastoma cell lines BE(2)C and SH-SY5Y as well as in Schwann cell line RT4-D6P2T by Western blot. Involvement of CXCL5 and JAK/STAT in ADSC-conditioned medium's neurotrophic effects was confirmed with anti-CXCL5 antibody and JAK inhibitor AG490, respectively. MAIN OUTCOME MEASURES: Neurotrophic effects of ADSC and PSMC-conditioned media were quantified by measuring neurite length in MPG cultures. Secretion of CXCL5 in these two media was quantified by ELISA. Activation of JAK/STAT by CXCL5 was quantified by densitometry on Western blots for STAT1 and STAT3 phosphorylation. RESULTS: MPG neurite length was significantly longer in ADSC than in PSMC-conditioned medium. CXCL5 was secreted eight times higher in ADSC than in PSMC-conditioned medium. Anti-CXCL5 antibody blocked the neurotrophic effects of ADSC-conditioned medium. CXCL5 activated JAK/STAT concentration-dependently from 0 to 50 ng/mL in RT4-D6P2T Schwann cells. At 50 ng/mL, CXCL5 activated JAK/STAT time-dependently, peaking at 45 minutes. AG490 blocked these activities as well as the neurotrophic effects of ADSC-conditioned medium. CONCLUSIONS: CXCL5 was secreted by ADSC at a high level, promoted MPG neurite growth, and activated JAK/STAT in Schwann cells. CXCL5 may contribute to ADSC's therapeutic efficacy on CN injury-induced ED.
INTRODUCTION: Previously we reported that paracrine actions likely mediated the therapeutic effects of adipose tissue-derived stem cells (ADSCs) on a rat model of cavernous nerve (CN) injury. AIM: To identify potential neurotrophic factors in ADSC's secretion, test the most promising one, and identify the molecular mechanism of its neurotrophic action. METHODS:Rat major pelvic ganglia (MPG) were cultured in conditioned media of ADSC and penile smooth muscle cells (PSMCs). Cytokine expression in these two media was probed with a cytokine antibody array. CXCL5 cytokine was quantified in these two media by enzyme-linked immunosorbent assay (ELISA). Activation of Janus Kinase/Signal Transducer and Activator of Transcription (JAK/STAT) by CXCL5 was tested in neuroblastoma cell lines BE(2)C and SH-SY5Y as well as in Schwann cell line RT4-D6P2T by Western blot. Involvement of CXCL5 and JAK/STAT in ADSC-conditioned medium's neurotrophic effects was confirmed with anti-CXCL5 antibody and JAK inhibitor AG490, respectively. MAIN OUTCOME MEASURES: Neurotrophic effects of ADSC and PSMC-conditioned media were quantified by measuring neurite length in MPG cultures. Secretion of CXCL5 in these two media was quantified by ELISA. Activation of JAK/STAT by CXCL5 was quantified by densitometry on Western blots for STAT1 and STAT3 phosphorylation. RESULTS: MPG neurite length was significantly longer in ADSC than in PSMC-conditioned medium. CXCL5 was secreted eight times higher in ADSC than in PSMC-conditioned medium. Anti-CXCL5 antibody blocked the neurotrophic effects of ADSC-conditioned medium. CXCL5 activated JAK/STAT concentration-dependently from 0 to 50 ng/mL in RT4-D6P2T Schwann cells. At 50 ng/mL, CXCL5 activated JAK/STAT time-dependently, peaking at 45 minutes. AG490 blocked these activities as well as the neurotrophic effects of ADSC-conditioned medium. CONCLUSIONS:CXCL5 was secreted by ADSC at a high level, promoted MPG neurite growth, and activated JAK/STAT in Schwann cells. CXCL5 may contribute to ADSC's therapeutic efficacy on CN injury-induced ED.
Authors: Anthony J Bella; Guiting Lin; Kavirach Tantiwongse; Maurice Garcia; Ching-Schwun Lin; William Brant; Tom F Lue Journal: J Sex Med Date: 2006-09 Impact factor: 3.802
Authors: Anthony J Bella; Guiting Lin; Ching-Shwun Lin; Duane R Hickling; Christopher Morash; Tom F Lue Journal: J Sex Med Date: 2009-03 Impact factor: 3.802
Authors: Yun-Ching Huang; Hongxiu Ning; Alan W Shindel; Thomas M Fandel; Guiting Lin; Ahmed M Harraz; Tom F Lue; Ching-Shwun Lin Journal: J Sex Med Date: 2010-02-05 Impact factor: 3.802
Authors: Anthony J Bella; Guiting Lin; Maurice M Garcia; Kavirach Tantiwongse; William O Brant; Ching-Shwun Lin; Tom F Lue Journal: Eur Urol Date: 2006-10-30 Impact factor: 20.096
Authors: Rong Yang; Yun-Ching Huang; Guiting Lin; Guifang Wang; Steven Hung; Yu-Tian Dai; Ze-Yu Sun; Tom F Lue; Ching-Shwun Lin Journal: Biochem Biophys Res Commun Date: 2009-01-29 Impact factor: 3.575
Authors: Guiting Lin; Maarten Albersen; Ahmed M Harraz; Thomas M Fandel; Maurice Garcia; Mary H McGrath; Badrinath R Konety; Tom F Lue; Ching-Shwun Lin Journal: Urology Date: 2011-04-13 Impact factor: 2.649
Authors: Thomas M Fandel; Maarten Albersen; Guiting Lin; Xuefeng Qiu; Hongxiu Ning; Lia Banie; Tom F Lue; Ching-Shwun Lin Journal: Eur Urol Date: 2011-08-04 Impact factor: 20.096
Authors: Qiwen Shen; Ken M Riedl; Rachel M Cole; Christopher Lehman; Lu Xu; Hansjuerg Alder; Martha A Belury; Steven J Schwartz; Ouliana Ziouzenkova Journal: J Agric Food Chem Date: 2015-02-12 Impact factor: 5.279